Intravenous chemotherapy injection of etoposide, billed in 10 mg increments

This code represents the administration of etoposide, a topoisomerase inhibitor chemotherapy drug, in a 10 mg dosage. Etoposide is primarily used in the treatment of various cancers by interfering with DNA synthesis and repair, leading to cell death.

This code is used when etoposide is administered parenterally, typically intravenously, for antineoplastic therapy. Documentation should clearly state the drug administered, the dosage in milligrams, and the route of administration.

• Report units based on 10 mg increments; for example, 100 mg would be coded as 10 units.
• Do not confuse with oral etoposide formulations, which are typically not separately billable under HCPCS.
• Ensure the medical record supports the specific dosage administered to avoid under or over-reporting.